Dynavax Technologies
DVAX
#5490
Rank
โ‚น115.75 B
Marketcap
โ‚น985.74
Share price
-0.09%
Change (1 day)
-9.72%
Change (1 year)

Dynavax Technologies (DVAX) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น58.26 Billion

According to Dynavax Technologies 's latest financial reports the company has โ‚น58.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dynavax Technologies - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น61.23 B-0.9%
2023-12-31โ‚น61.79 B19.6%
2022-12-31โ‚น51.66 B27.15%
2021-12-31โ‚น40.63 B236.67%
2020-12-31โ‚น12.06 B12.05%
2019-12-31โ‚น10.77 B5.85%
2018-12-31โ‚น10.17 B-16.93%
2017-12-31โ‚น12.25 B121.42%
2016-12-31โ‚น5.53 B-57.55%
2015-12-31โ‚น13.03 B67.67%
2014-12-31โ‚น7.77 B-33.56%
2013-12-31โ‚น11.69 B70.77%
2012-12-31โ‚น6.85 B13.65%
2011-12-31โ‚น6.02 B86.46%
2010-12-31โ‚น3.23 B89.76%
2009-12-31โ‚น1.70 B-48.23%
2008-12-31โ‚น3.29 B-4.97%
2007-12-31โ‚น3.46 B7.37%
2006-12-31โ‚น3.22 B-4.56%
2005-12-31โ‚น3.37 B18.53%
2004-12-31โ‚น2.85 B115.25%
2003-12-31โ‚น1.32 B-6.07%
2002-12-31โ‚น1.41 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Agenus
AGEN
โ‚น0.31 B-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น356.19 B 511.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.638 T 2,711.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น660.96 B 1,034.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น735.88 B 1,163.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚น399.72 B 586.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น1.347 T 2,213.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น198.13 B 240.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚น849.48 B 1,357.98%๐Ÿ‡บ๐Ÿ‡ธ USA